/5
0 avis
Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status
Archive ouverte
Edité par CCSD ; Lippincott, Williams & Wilkins -
International audience
Consulter en ligne
Chargement des enrichissements...